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started to be used in pharmaceutical by 
1960 when chlordiazepoxide was 
produced and introduced commercially as 
a medicine under the trade name of 
Librium ®. Chlordiazepoxide which initially 
called methaminodiazepoxide was the first 
benzodiazepine that has been synthesized 
in 1950s. This compound was accidentally 
produced when the chemical work of dye 
was carried out, later when the test was 
made the scientist found that this 
compound had anxiolytic, hypnotic and 
muscle relaxant effects. Soon after this 
first invention, many benzodiazepine 
derivatives were discovered, produced 
and introduced to the market. 
Due to clinical and biological 
activities as well as commercial success of 
1,4-benzodiazepine family of CNS active 
agents, the interest in extensive 
development of this compound derivatives 
has risen among medicinal chemistry 
community as privileged structures. 
Through modification of origin 
structures many compounds which were 
proven to give the biological activities 














important compounds including diazepam 
which was first marketed as Valium®, 
alprazolam was designed by introducing 
the heterocyclic ring fused to different 
faces of the benzodiazepine ring nucleus. 
Moreover, the development of this drug 
can also carried out by replacing benzene 
ring with other ring constituents like 
naphthalene, imidazole, furan, pyridine and 
pyrimidine. The following diagram shows 
some important benzodiazepines. 
 
Figure 1. Some important benzodiazepines 
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ABSTRACT 
Synthesis of 1,4-Benzodiazepine via reaction of ethylendiamine with 3-phenyl-1,2-dioxine has been 
carried out. The first step of this experiment was conversion of triphenyl phosphine to triphenyl metyl 
phosphine iodide which was then used to form phenyl butadiene from cinnamaldehyde. The synthesis 
of phenyl dioxine was done via photochemical reaction of phenyl butadiene with oxygen gas in the 
presence of tetraphenyl posphene. The coupling reaction between phenyl phosphine and 
ethylendiamine was carried out under atmospheric pressure at room temperature. All steps of these 
reactions were confirmed using TLC with appropriate eluents and the resulting compounds were 
purified using column chromatography. In addition, all products structure including phenyl dioxine and 
1,4-benzodiazepine were determined using HNMR. 
Keywords: Benzodiazepine, photochemical reaction, dioxine 
 
Chimica Didactica Acta  Nazar, M 
76 
 
Synthesis of diazepines  
Even though some diazepines 
have been found naturally from several 
sources like Liposidomycins which was 
found in Streptomyces griseosporous 
(Knapp et al, 1992), Asmarines A and B 
(Bridson and Weirich, 1988; Colombo et 
al, 1989) were isolated from sponge 
Raspalila sp. and benzomalvin A was 
extracted from the culture of Penicillium 
sp., the development of this family 
compounds remains interesting to 
chemists until present days.  
Two main approaches including 
chiral synthesis and combinatorial 
synthesis can be employed to obtain the 
family compound of benzodiazepines. 
Gilman et al, 1990 pioneered the 
synthesis of first optically active 
benzodiazepine compound and Herrero et 
al, 2003 have also successfully synthesize 
some important chiral 1,4-benzodiazepine 
derivatives. However, a versatile approach 
which has been used by many chemists is 
combinatorial synthesis. This method 
allows researchers to develop various 
derivatives of benzodiazepines with varied 
biological activities. By changing the 
substituents or rings of reactants involved 
in synthesis of benzodiazepines, many 
chemists have successfully synthesized 
bunch of diazepine derivatives which 
some of them will be discussed in this 
section. For example, Bunin et al, 1994 
reported the successful combinatorial 
synthesis of 1,4-benzodiazepine library 
and had also evaluated the biological 
activities of synthesized compounds.  
In 1993, Akssira et al had 
successfully synthesized the compound of 
1,4 benzodiazepine 2,5-diones through 
combination of anthranilic acid derivative 
and amino esters by using HCl gas as a 
catalyst. Furthermore, diazepines can also 
be made through the reaction of 1, 3-
diketoester compounds with 
ethylendiamine by heating at 60oC as 
suggested by Kumar and Joshi, 2009. The 
following scheme illustrates the synthesis 
of benzodiazepines. 
Some Important clinical activities of 
1,4-benzodiazepines  
Anti-malarial agents  
Falcipain-2 (FP-2) inhibitors was 
designed by Micale et al. which is based 
on a 1,4- benzodiazepine scaffold. This 
compound is introduced internally to a 
peptide sequence, which mimics the 
fragment D-Ser-Gly, and on a C-terminal 
aspartyl aldehyde building block, which 
inhibits the enzyme by forming a 
reversible covalent bond at the active site. 
The following diagram shows the structure 
of Falcipain-2. 
Anti Bacterial Agents  
Tibenzonium iodide with 
systematic name of Diethylmethyl (2- ( (4-   
(p (phenylthio) phenyl) – 3 H – 1 , 5 -
benzodiazepin-2-yl) thio) ethyl) ammonium 
iodide is one of benzodiazepine 
derivatives which has anti-infective activity 
and anti-bacterial activity and has been 
reported to have antibacterial activity 
against Streptococus pyogenes. The 
following image illustrates the structure of 
tibenzonium iodide. 
Anti-viral agents  
Drug from the family of Non-
nucleoside reverse transcriptase inhibitors 
or usually abbreviated as (NNRTIs) were 
reported to give the therapeutic effect 
against human immunodeficiency virus-1 
(HIV-1) which are targeted at a specific 
site of reverse transcriptase. 
Anti-hypertensive agents  
Some of family compound of 
diazepines were found to possess anti-
hypertensive activity. When guanidine 
group combined with tetrahydro-1,4-
benzodiazepine the resulted compound 
give the anti-hypertensive action. In 
addition, the fusion of benzodiazepine to 
indole also showed the anti-hypertensive 
activity. The following figure illustrates the 
chemical structures of drugs synthesized 
by Kim, 1995 which were proven to give 
the therapeutic effect against blood 
hypertension. 
RESEARCH METHOD 
Chemicals and Instruments  
The chemicals involved in this 
experiment including dichloromethane, 
ethylacetate, triphenyl phosphine, 
tetraphenylphosphine, potassium 
 
Chimica Didactica Acta  Nazar, M 
77 
 
butoxide, cinnamaldehyde, methanol, 
diethyl ether, methyl iodide, saturated 
sodium carbonate, oxygen gas, 
ethylendiamine petroleum spirit and silica 
gel. In purification using Thin Layer 
Chromatography the aluminum base silica 
plate was used while in column 
chromatography silica gel was utilized. For 
structural analysis, HNMR was used. 
Preparation of triphenylmetyl 
phosphine salt  
46 g of methyl iodate was 
dissolved in 150 mL dried diethyl ether 
and stirred. In to this stirred solution 92.8 g 
triphenyl phosphine was gently added 
resulted in precipitation of product in the 
bottom of the flask, subsequently the 
resulting product was then filtered under 
reduced pressure and washed several 
times using diethyl ether.  
Synthesis of 1-phenyl-1,2-butadiene  
Dried diethyl ether was prepared 
by distillation.  50 mL of distilled diethyl 
ether was taken using a syringe and 
placed in to 250 mL round bottle flask. 
16.2 g of triphenyl phosphonium iodide 
was then added and dissolved by stirring 
for 30 minutes followed by addition of 
potassium butoxide while the stirring was 
continued, After 30 minutes, 5 g of 
cinnamaldehyde was added to the flask 
resulted in turn of mixture colour to pale 
orange solid. In order to ensure that all 
cinnamaldehyde completely react, couple 
grams of potassium butoxide was added 
to the mixture. Upon the completion of 
reaction the brown oily product was 
obtained and TLC of product along with 
starting material was carried out using the 
eluent of 2.5% ethyl acetate in petroleum 
ether. The product obtained then was 
purified by column chromatography using 
silica as stationary phase and the same 
mobile phase as in TLC. The fraction of 3, 
4 and 5 were combined together followed 
by evaporation of the eluent under 
reduced pressure. 2.35 g product which 
was obtained then was stored in the 
refrigerator for further reaction. 
Photolytic synthesis of 3-phenyl-1, 2-
dioxine  
1-phenyl-1,3-butadiene which was 
obtained previously was diluted in dichloro 
methane and 20 mg of tetra phenyl 
phosphine was added and the resulting 
solution was violet, the solution was put in 
a reactor and was bubbled by O2 and 
emitted by light source for 7 hours. The 
product then was purified by TLC followed 
by column chromatography involving 10% 
ethyl acetate in petroleum ether as an 
eluent. Upon completion of 
chromatographic purification, all fractions 
were tested by TLC then the fraction of 11 
to 15 were collected and combined and 
the solvent was evaporated under reduced 
pressure rotary evaporator. 410 mg 
product was obtained and stored for 
further reaction with ethylendiamine to 
produce the final product.  
 
Reaction of 3-phenyl-1,2-dioxine with 
ethylendiamine 
Synthesis of 1,4-benzodiazepine 
was carried out at room temperature and 
pressure. 200 mg of product from previous 
reaction 3-phenyl-1,2-dioxine was mixed 
and reacted with 1.5 molar ratio of 
ethylendiamine in dichloromethane and 
stirred for 3 days until the reaction 
complete. 
 
RESULTS AND DISCUSSIONS  
Preparation of triphenylmetyl 
phosphine salt  
The first step of this research was the 
preparation of triphenylmetyl phosphine 
salt by reacting the methyl iodide and 
triphenyl phospene in dried dietyl ether 
which produced the white powder. The 







Synthesis of 1-phenyl-1,2-butadiene  
The reaction was carried out under 
the fumehoodand. Triphenyl phosphonium 
iodide was reacted with potassium 
butoxide. Upon the addition of potassium 
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butoxide the mixture turned yellow. The 
reaction then perceed by adding 
cinnamaldehyde which resulted pale 
brown solid. The reaction is illustrated by 




The TLC of 1-phenyl-1,2-butadiene 
compared to the starting material can be 
seen in figure 1. 
 









Figure 1 . TLC of 1-phenyl-1,3-butadiene 
vs cinamaldehyde (A) and Dioxine (B) 
The product with Rf =0.375 was obtained, 
the TLC spot of product was close to the 
spot of dye (tetraphenyl phosphine). TLC 
of dioxine (B) after purification using 
column chromatograpy with eluent of 10% 
ethyl acetate in petroleum spirit. The 
following figure depicted the TLC of final 
product (1,4-benzodiazepine) fragments 
collected after purification using culomn 
chromatography involving silica gel as 
adsorbant and the eluent of 10% ethyl 
acetate in petroleum spirit. 
 
 
Figure 2. TLC spectra of 1,4 
Benzodiazepines 
Fractions of 11, 12, 13,14,15 and 
16 were collected and combined followed 
by evaporation under reduced pressure. 
Mass of product obtained was 0.41 g.  
 
synthesis of 3-phenyl-1, 2-dioxine  
The photochemical reaction of 3-
phenyl-1, 2-dioxine was carried out in the 
reactor equiped by the O2 filled balloon 





In the reaction depicted, the 
diatomic molecule of O2 started to open 
the double bond initiated by the foton and 
formed the ring with two carbons exist in 
the molecule of 1-phenyl-1,2-butadiene. 
 After the reaction of 3-phenyl-1, 2-
dioxine was completed about 7 hours. The 
synthesis of 1,4-benzodiazepine was 
carried out by mixing the 3-phenyl-1, 2-
dioxine with ethylendiamine as shown by 




The final product produced was then 
analysed by TLC and H-NMR. The 
following TLC spectrum shown the spot 
of product. 
The TLC of final product (1.4-






















Figure 4. HNMR at time of reaction of t=0 
 
 
Figure 5. HNMR at time of 1 hour 
 
 
Figure 6. HNMR Spectra at t=16 hours 
 
 
Figure 7. HNMR Spectra at t=24 hours 
 
 
Figure 8. HNMR Spectra of dioxine 
 




The above diagram depicted the 
overall reaction of dioxine with 
ethylendiamine resulted in the final 
product of 1,4-benzodiazepine. As can be 
seen in the scheme that the reaction 
proceeded through nucleophilic attack by 
ethylendiamine and the reaction went to 
some slow process and fast process, 
during the reaction there is an 
intermediate formation of product A as 
marked in the reaction scheme above thus 
product A can be observed in the spectra 
at t=1 and t= 16 hours.  
However, as the reaction complete 
i.e at t=24 hours, thesignal for product A 
no longer appear in the spectra. If we 
compare the spectra of reaction at t=16 
against t=24, it is clearly observed that the 
signal at 5.2 ppm which appears in t=16 
but not at t=24. In addition, the 
overlapping signal between 2.5 ppm and 
4.2 ppm at t=16 indicates the mixture of 
 
Chimica Didactica Acta  Nazar, M 
80 
 
product A and final product is no longer be 
seen at t=24 which is the indication of 
complete reaction. 
The HNMR spectra for the final 
product at time zero of reaction to t=24 
hours are given in the appendixes 3, 4, 5 
and 6. As can be seen that at t=0 the 
signal of ethylendiamine and starting 
material of dioxine are observed. When 
we compare the spectra for dioxine 
(Figure 8) to the spectra of reactant 
mixture at t=0 (Figure 4) the similar 
spectra can be seen except the presence 
of ethylendiamine in the mixture which 
cannot be seen in thedioxine spectra. 
The compound resulted in this 
experiment was determined by HNMR but 
the spectra produced was not sufficiently 
good enough. In addition, unfortunately 
the purification of the resulted compound 
also was not very successful since at the 
end of purification process, the desired 
spectra which were expected to appear 
did not show up. 
TLC was run to investigate the 
completion of coupling reaction between 
ethylendiamine and dioxine but it seems 
that the eluent used (10% methanol in 
dichloromethane) for TLC and column 
chromatography was not suitable enough. 
Therefore we would suggest the 
comprehensive investigation in order to 
find an appropriate eluent that can be 
used to purify the compound that 
produced in this experiment. 
 
CONCLUSION 
In conclusion, the synthesis of 1,4-
benzodiazepine through coupling reaction 
between ethylene diamine and 1-phenyl-
1,3-dioxine was handy to perform since 
the reaction can be carried out at room 
temperature and atmospheric pressure.  
However, this reaction is time 
consuming process and dioxine as an 
important reactant was prepared through 
photochemical reaction involving oxygen 
gas. This experiment has only covered the 
synthesis of 1,4-benzodiazepine 
compound which has the chemical 
structure as depicted in the last reaction. 
However, the biological or clinical activities 
of this compound is necessary to be 
investigated and by obtaining the 
pharmaceutical activities we can then 
know whether this compound can be used 
as a medicine with specific therapeutic 
effect in order to cure particular disease. 
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